Chantix is a stop smoking drug which was heavily advertised by Pfizer in direct-to-consumer advertisements until earlier this year. Most of the branded ads were pulled after safety concerns emerged about psychiatric side effects of Chantix which could increase the risk of suicide. However, new ad campaigns are beginning to… Read more.
In today’s information age, consumers turn to the internet to research important concerns in their life. Given the recent reports about an association between Chantix and suicides, many potential users of the anti-smoking drug have likely visited the official site for the medication to determine whether the risk of suicidal… Read more.
Recent reports suggest that there is an association between the use of the anti-smoking drug Chantix and suicide. Drug regulators in the United States and Europe are investigating hundreds of suicides, reports of suicidal thoughts and severe behavior changes which occurred among users within a few weeks of taking the… Read more.
Before a new drug is sold, the manufacturer is supposed to establish that it is safe and effective through a series of clinical trials. However, in the case of the stop-smoking medication Chantix, problems which have recently linked the drug to reports of suicides and suicidal thoughts, were not fully… Read more.
Since its approval in May 2006, many people have turned to Chantix to stop smoking. While the medication was initially presented as one with very few side effects, Chantix has since been associated with numerous reports of suicides and other potentially serious injuries caused by unusual behavior while taking the… Read more.
On Friday, the FDA issued an alert highlighting important changes made to the Warnings and Precautions section of the Chantix label. Psychiatric symptoms, such as severe changes in mood and behavior, have been associated with the antismoking drug. There have been numerous reports of individuals who committed suicide on Chantix,… Read more.
The FDA has issued an alert to healthcare providers regarding an increased suicide risk associated with 11 different antiepileptic drugs, including Neurontin, Lamictal, Lyrica, Trileptal and Topamax. A review of prior clinical trials demonstrated that users of the drug were more likely to commit suicide, attempt suicide or have suicidal… Read more.
Given concerns about medications with potential side effects that may increase the risk of suicidal thoughts or suicidal behavior, the FDA has instituted a new policy which will require drug manufacturers to examine whether patients become suicidal during clinical studies. The new policy was developed following the discovery that several… Read more.
Pfizer indicated late last week that they are going to update the Chantix warning label. Information will be placed more prominently which suggests that doctors should monitor users of the drug for signs of suicidal thoughts and suicidal behavior. The lawyers at Saiontz & Kirk, P.A. are reviewing potential Chantix… Read more.
Reports of suicide and erratic behavior have been associated with the use of Chantix, a medication which is designed to help people stop smoking. Last month the FDA issued a statement that they are reviewing the possible Chantix suicide side effects and that there have been over 100 reports received… Read more.
